Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Nearly 30 years of experience in the Korean/Asian equity research. Major sectors coverage include the following:
- Technology 
- Consumer 
- Special Situations/Deep Value Plays
- Tender Offers/M&As
- Holdcos/Stubs
- Asian Unicorns/Private Companies

Korea/Asia, Events, IPOs

End of Mandatory Lock-Up Periods for 41 Companies in Korea in July 2023

Lunit (Specializes in AI-Based Cancer Diagnosis and Treatment): Rights Offering of 202 Billion Won

KOSDAQ150 Rebalance in December 2023 Highlighted by Locals

Equity Capital Markets

<ul>
<li>Lunit is getting ready to complete its IPO in Korea in July. The IPO base deal size is from $42 million to $46 million.</li>
<li>Established in 2013, Lunit is one of the leading companies in Korea that specializes in AI-based cancer diagnosis and treatment solutions.</li>
<li>Lunit is a pioneer in the medical artificial intelligence industry. The company has developed and commercialized AI-assisted detection solutions that complement human visual limitations through deep learning technology. </li>
</ul>


Lunit is getting ready to complete its IPO in Korea in July. The IPO base deal size is from $42 million to $46 million.
Established in 2013, Lunit is one of the leading companies in Korea that specializes in AI-based cancer diagnosis and treatment solutions.
Lunit is a pioneer in the medical artificial intelligence industry. The company has developed and commercialized AI-assisted detection solutions that complement human visual limitations through deep learning technology. 


루닛 IPO 미리보기: AI 기반 암 진단 및 치료 솔루션의 선구자